MBX Biosciences (MBX) Change in Cash (2023 - 2026)
MBX Biosciences (MBX) reported Change in Cash of -$29.9 million for Q1 2026, down 53.59% on a YoY basis from -$64.4 million in Q1 2025, and up 79.8% sequentially from -$147.8 million in Q4 2025.
MBX Biosciences (MBX) Change in Cash (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Change in Cash data on file, last reported at -$29.9 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 53.59% year-over-year to -$29.9 million; the trailing twelve-month figure through Mar 2026 stood at $15.5 million (up 380.99% YoY), and the FY2025 full-year result was $25.9 million, up 37.76% from the prior year.
- Change in Cash improved to -$29.9 million in Q1 2026, from -$147.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $183.3 million in Q3 2025 to a low of -$147.8 million in Q4 2025.
- A 4-year average of -$2.5 million and a median of -$21.2 million in 2024 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 143.09% in 2025, while the deepest fall reached 496.74% in 2025.
- Tracing MBX's Change in Cash over 4 years: stood at -$40.1 million in 2023, then slumped by 108.36% to -$83.5 million in 2024, then plunged by 77.02% to -$147.8 million in 2025, then jumped by 79.8% to -$29.9 million in 2026.
- Business Quant data shows MBX's Change in Cash at -$29.9 million in Q1 2026, -$147.8 million in Q4 2025, and $183.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | -29.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.87 Mn |
| Dec 31, 2025 | -147.84 Mn |
| Sep 30, 2025 | 183.34 Mn |
| Jun 30, 2025 | 9.88 Mn |
| Mar 31, 2025 | -19.45 Mn |
| Dec 31, 2024 | -83.51 Mn |
| Sep 30, 2024 | 120.36 Mn |
| Jun 30, 2024 | -22.92 Mn |
| Mar 31, 2024 | 4.90 Mn |
| Dec 31, 2023 | -40.08 Mn |